PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “Transurethral Resection of Prostate”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 631 records · Page 35Linked to original sources

Procoagulant properties of benign and malignant prostatic tissue.

OBJECTIVE: To determine the factor-X activating procoagulant activity (FXAA) of prostatic tissue removed at transurethral resection in a specific chromogenic assay. PATIENTS AND METHODS: FXAA was extracted from transurethrally resected prostatic tissue using a cryofragmentation technique. Tissue from 50 patients with prostate cancer was analysed and compared with that from 36 control patients with benign prostatic-hypertrophy. Enzyme activities were assayed in a two stage chromogenic assay and correlated with conventional markers of tumour aggressiveness. RESULTS: FXAA was found to be significantly lower (P < 0.001) in tissue from malignant prostates compared with benign prostatic hypertrophy tissue. Loss of FXAA was also related to Gleason grade (P < 0.03), percentage of chips involved by tumour (P < 0.04) and bone scan status (P < 0.02). Using antibody inhibition tests this procoagulant was characterized as being a factor VII/tissue factor complex. CONCLUSIONS: Malignant change in the prostate is associated with a reduction in FXAA and this may be an important factor in prostatic tumour growth and dissemination.

Biomarkers, Tumor↗

[Intraoperative blood recovery in transurethral resection of prostate (TURP)].

Blood collected from irrigating fluid in TURP was studied if it was appropriate blood as autologous transfusion or not. TURP was performed aided by continuous irrigation through suprapubic cystostomy. The cystostomy tube was connected to the Shiley STAT or Haemonetics Cell Saver in 15 patients. The average weight of resected adenoma was 36 g per patient. The product of washed blood gave an average yield of 440 ml per patient with an average RBC count of 469 x 10(3)/mm3, hemoglobin of 14.6 g/dl, hematocrit of 44.8%, platelets of 15400/mm3. The half-life of collected red blood cells tagged with 55Cr was 22 days. The urine in 10 patients (67%) were contaminated with bacteria before TURP, and 3 of collected blood were contaminated with bacteria (20%). As for carcinoma cells, cultured urinary bladder carcinoma cells (T24) and renal carcinoma cells (ACHN) were completely eliminated after filtration through leukocyte removal filter Sepacell or Pall RC. As results, the intraoperatively collected blood from irrigating fluid in TURP was useful and safe as autologous blood transfusion.

Blood Transfusion, Autologous↗

[Autologous blood retransfusion in transurethral resection of prostate (TURP)].

UNLABELLED: Blood collected from the irrigation fluid used during TURP was retransfused in 17 patients. Of the 17 patients, 8 cases were also transfused preoperatively reserved blood. The weight of resected adenoma (g), resection time (minutes), the volume of salvaged blood (ml) of 9 cases who were transfused only salvaged autologous blood were 30.6 g, 63 min. and 355 ml, respectively, and those of 8 patients who were given both salvaged and preoperatively reserved autologous blood were 46.1 g, 78 min. and 703 ml, respectively. No patient was transfused homologous blood. Preoperative urine cultures showed contamination of bacteria in 12 cases (70.6%), and the blood concentrated from irrigated fluid was positive for bacteria in 2 cases (11.8%). Blood count (RBC, Hb, Ht) just after TURP, after blood retransfusion, at the next and the 7th day after the operation were compared to those of just before TURP (Blood Count Ratio). The ratio of the 9 cases who received only salvaged blood were 83.5%, 96.8%, 90.9%, 85.2% each and the ratio of the 8 cases who were transfused both salvaged and preserved blood were 86.9%, 102.6%, 101.4%, 97.5% each. There were no adverse effects due to the autologous blood retransfusion. CONCLUSION: Retransfusion of salvaged autologous blood from the irrigating fluid of TURP was clinically safe and effective. No homologous blood was transfused in TURP when salvaged autologous blood with or without preserved blood was retransfused to the patient.

Blood Transfusion, Autologous↗